Shandong Buchang Pharmaceuticals Co., Ltd.SSE: 603858

Announcement on Progress in the Proposed Transfer of Holding Subsidiary Equity

· Issued by Shandong Buchang Pharmaceuticals Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

Shandong Buchang Pharmaceuticals Co., Ltd. has announced progress regarding the proposed transfer of equity in its holding subsidiary, Hunan Zhongce Biotechnology Co., Ltd. The company has completed the necessary registration changes and obtained a new business license following the transfer. Investors are cautioned about potential market, management, and operational risks following this transaction.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Progress in the Proposed Transfer of Holding Subsidiary Equity

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Shandong Buchang Pharmaceuticals Co., Ltd. on 6ix

Earlier from Shandong Buchang Pharmaceuticals

Later from Shandong Buchang Pharmaceuticals

All Shandong Buchang Pharmaceuticals news releases